Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02455557 |
|---|---|
| Brief Title: | SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma |
| First Submitted : | May 22, 2015 |
| First Submitted that Met QC Criteria : | May 22, 2015 |
| First Posted : | May 28, 2015 (Estimate) |
| Results First Submitted : | December 17, 2020 |
| Results First Submitted that Met QC Criteria : | January 12, 2021 |
| Results First Posted : | February 1, 2021 |
| Last Update Submitted that Met QC Criteria : | March 21, 2022 |
| Last Update Posted : | March 31, 2022 |